Next Meeting: Tuesday, June 3, 2025.

Platform technology for vaccines is recently included in the veterinary legislation and it is also anticipated to be part of the new pharmaceutical legislation. Applicants can apply for this pipeline meeting with new innovative developments and challenges related to:

1. Platforms for medicinal products manufactured using prior knowledge, such as common manufacturing platform approaches;
2. Platforms for medicinal products against agents which are or have a potential to cause serious cross-border threats to health e.g. pandemic/pandemic preparedness; 
3. Platforms for the manufacture of personalised or individualised medicines, e.g. covering different ultra-rare orphan indications. 

Applicants with focus on human medicinal products as well as veterinary medicinal products are invited to apply. CCMO will participate for human medicinal products.   
Applicants are informed that no scientific advice will be provided during pipeline meetings and the discussion will focus on new innovative developments and challenges in the portfolio of the company.

Registration deadline: Friday, April 11, 2025.

After the registration deadline, the MEB will select three companies from the submissions. The selected companies will be informed via email about their scheduled pipeline meeting. Companies that are not selected will receive a rejection notice via email. Notifications can be expected on Friday, April 18, 2025. 

If a pharmaceutical company is selected to participate in a specific pipeline meeting, we ask the company to provide a briefing document to help the MEB participants prepare for the meeting. This briefing document should be submitted no later than Friday, May 2, 2025.